World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
61
Citations
11204
World Ranking
9403
National Ranking
2648

Sander G. Mills publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Sander G. Mills sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 212 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Sander G. Mills D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Sander G. Mills sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 61 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Sander G. Mills is affiliated with MSD (United States) in the United States. Their professional background is linked to this major organization, reflecting a career embedded within a prominent entity in the pharmaceutical sector.

There are no published papers currently listed under their name in the available data, and no frequent co-authors have been identified. Similarly, there are no specific publication venues associated with their work, which limits insight into their research dissemination channels.

No book publications have been attributed to Mills, which suggests that their contributions have not extended into this form of academic output at this time.

Information about their main fields of study, subfields, and primary research topics is not available. This absence of detailed disciplinary focus or thematic specialization indicates either a broad professional role or limited public documentation of their specific areas of expertise.

There are no recorded awards linked to Sander G. Mills, providing no current evidence of recognition through formal accolades or distinctions in their field.

Mills is currently living, and the available data presents a professional profile that is factual but limited in scope, particularly regarding scholarly output and research impact. The affiliation with MSD implies engagement with industry-related activities within the life sciences or pharmaceutical domain.

Best Publications

  • Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

    Mark S. Kramer;Neal Cutler;John Feighner;Ram Shrivastava

  • Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

    M. Forrest;S.-Y. Sun;R. Hajdu;J. Bergstrom

  • Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

    J. J. Hale;S. G. Mills;M. Maccoss;P. E. Finke

  • Chemistry of tricarbonyl hemiketals and application of Evans technology to the total synthesis of the immunosuppressant (-)-FK-506

    Todd K. Jones;Robert A. Reamer;Richard Desmond;Sander G. Mills

  • Src kinase inhibitor compounds

    Julianne A. Hunt;Sander G. Mills;Peter J. Sinclair;Dennis M. Zaller

  • Morpholine and thiomorpholine tachykinin receptor antagonists

    Conrad P. Dorn;Paul E. Finke;Jeffrey J. Hale;Malcolm MacCoss

  • Total synthesis of immunosuppressant (-)-FK-506

    Todd K. Jones;S. G. Mills;R. A. Reamer;D. Askin

  • Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.

    Carina P. Tan;Yue Feng;Yun Ping Zhou;George J. Eiermann

  • Pyrrolidine modulators of chemokine receptor activity

    Charles Caldwell;Kevin T. Chapman;Jeffrey Hale;Dooseop Kim

  • Solvent effects on keto-enol equilibria: tests of quantitative models

    Sander G. Mills;Peter Beak

  • Selective s1p1/edg1 receptor agonists

    George A. Doherty;Michael J. Forrest;Richard Hajdu;Jeffrey J. Hale

  • Edg receptor agonists

    Robert L. Bugianesi;George A. Doherty;Amy Gentry;Jeffrey J. Hale

  • Pyrrolidine and piperidine modulators of chemokine receptor activity

    Richard J. Budhu;Jeffrey J. Hale;Edward Holson;Christopher Lynch

  • Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties.

    Dooseop Kim;Liping Wang;Jeffrey J. Hale;Christopher L. Lynch

  • The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

    F.D Tattersall;W Rycroft;M Cumberbatch;G Mason

  • Spiro-substituted azacycles as modulators of chemokine receptor activity

    Sander G. Mills;Malcolm MacCoss;Martin S. Springer

  • Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P1) Receptor Agonists with Exceptional Selectivity against S1P2 and S1P3

    Zhen Li;Weirong Chen;Jeffrey J Hale;Christopher L Lynch

  • Substituted imidazoles as cannabinoid receptor modulators

    Paul E. Finke;Sander G. Mills;Christopher W. Plummer;Shrenik K. Shah

  • Heterocyclic amide compounds as cell adhesion inhibitors

    Philippe L Durette;William K Hagmann;Malcolm Maccoss;Sander G Mills

  • Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720

    Jeffrey J. Hale;William Neway;Sander G. Mills;Richard Hajdu

Frequent Co-Authors

Malcolm Maccoss
Malcolm Maccoss MSD (United States)
Jeffrey J. Hale
Jeffrey J. Hale MSD (United States)
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Ralph P. Volante
Ralph P. Volante MSD (United States)
Michael W. Miller
Michael W. Miller MSD (United States)
Kevin T. Chapman
Kevin T. Chapman MSD (United States)
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Catherine D. Strader
Catherine D. Strader MSD (United States)
Robert A. Reamer
Robert A. Reamer MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA can open doors to a variety of related fields and career paths. For those interested in law enforcement or legal support roles, exploring the best online associates in criminal justice programs can be a great start. These degrees offer foundational knowledge and flexible online options for students.

If you're considering a role that bridges chemistry and legal work, obtaining a paralegal certificate might complement your expertise and open new professional opportunities with competitive salaries.

For science graduates eyeing the pharmaceutical industry, a career as a pharmaceutical sales representative offers a dynamic path. Understanding the pharmaceutical sales salary and career trajectories can help in making informed decisions about this rewarding sector.

Alternatively, pursuing a healthcare profession such as pharmacy requires meeting specific credentials. Reviewing the key steps to become a pharmacist can provide clarity on the educational and licensing requirements to thrive in this essential field.

Best Scientists Citing Sander G. Mills

Trending Scientists

Recently Published Articles